Impact of perioperative chemotherapy on oncological outcomes after gastric cancer surgery

Neoadjuvant Chemotherapy for Nonmetastatic Esophago-Gastric Adenocarcinomas: A Systematic Review and Meta-Analysis

(2013) Chun-Dong Zhang et al.   CANCER INVESTIGATION

Perioperative chemotherapy for resectable gastroesophageal cancer: A single-center experience

(2013) R. Molina et al.   EJSO

Outcomes among patients treated for gastric adenocarcinoma during the last decade

(2013) E.A. Bringeland et al.   JOURNAL OF SURGICAL ONCOLOGY

The problem of the poor control arm in surgical randomized controlled trials

(2012) O. Strobel et al.   BRITISH JOURNAL OF SURGERY

MAGIC in practice: Experience of peri-operative ECF/X chemotherapy in gastro-esophageal adenocarcinomas

(2012) A.M. Reece-Smith et al.   JOURNAL OF SURGICAL ONCOLOGY

A meta-analysis of D1 versus D2 lymph node dissection

(2011) Rajini Seevaratnam et al.   Gastric Cancer

Guidelines for the management of oesophageal and gastric cancer

(2011) W. H. Allum et al.   GUT

Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer

(2011) Mitsuru Sasako et al.   JOURNAL OF CLINICAL ONCOLOGY

Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial

(2011) Marc Ychou et al.   JOURNAL OF CLINICAL ONCOLOGY

Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2010) A. Okines et al.   ANNALS OF ONCOLOGY

Introducing national guidelines on perioperative chemotherapy for gastric cancer in Norway: A retrospective audit

(2010) T. Hølmebakk et al.   EJSO

Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954

(2010) Christoph Schuhmacher et al.   JOURNAL OF CLINICAL ONCOLOGY

Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial

(2010) Ilfet Songun et al.   LANCET ONCOLOGY

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER